Published - June 24, 2021 09:20 pm IST - Mumbai
Veeda Clinical Research has announced that it has raised $16 million in a round led by private equity fund, Sabre Partners.
This round also saw participation from HNIs such as Pranab Mody (of JB Chemicals), Havells India family office, Nikhil Vora (fFounder of Sixth Sense Ventures) and Arjun Bhartia (of Jubilant).
Ajay Tandon, MD, Veeda said, “We will continue to invest in developing our delivery capabilities, to be increasingly relevant to our clients objectives.”
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
